☆Soleus Capital Management, L.P.
Quality Q
0.426
AUM ($M)
2,902
Positions
97
Turnover
0.26
Top-10 wt
49%
Herfindahl
0.037
History (qtrs)
6
Excess Return
—
AI Eval Run AI Eval
Holdings · 115 positions · portfolio value $2,902M
| Ticker | Name | Activity | Security Type | Weight | Δ Weight | Value ($M) | Shares | Δ Shares | Qtrs Held | Excess Return |
|---|---|---|---|---|---|---|---|---|---|---|
| ☆KRYS funds › | KRYSTAL BIOTECH INC | TRIM | — | 12.0% | -0.0% | 349.1 | 939,254 | -213,833 | 5 | — |
| ☆CELC funds › | CELCUITY INC | ADD | — | 6.1% | +0.2% | 178.3 | 1,704,318 | +419,940 | 5 | — |
| ☆TGTX funds › | TG THERAPEUTICS INC | TRIM | — | 5.5% | +0.1% | 160.9 | 2,927,895 | -1,101,424 | 5 | — |
| ☆PODD funds › | INSULET CORP | ADD | — | 5.5% | +0.7% | 159.7 | 1,049,000 | +486,500 | 3 | — |
| ☆NVCR funds › | NOVOCURE LTD | TRIM | — | 5.2% | +0.5% | 150.2 | 9,913,401 | -578,990 | 5 | — |
| ☆UTHR funds › | UNITED THERAPEUTICS CORP DEL | ADD | — | 4.2% | -0.3% | 122.2 | 225,587 | +38,400 | 5 | — |
| ☆INSP funds › | INSPIRE MED SYS INC | ADD | — | 3.0% | +1.8% | 86.2 | 1,931,436 | +1,355,137 | 5 | — |
| ☆RIGL funds › | RIGEL PHARMACEUTICALS INC | ADD | — | 2.5% | +2.5% | 72.1 | 1,843,504 | +1,833,504 | 5 | — |
| ☆ANIP funds › | ANI PHARMACEUTICALS INC | ADD | — | 2.5% | -0.1% | 71.8 | 867,760 | +47,517 | 5 | — |
| ☆BBNX funds › | BETA BIONICS INC | ADD | — | 2.4% | +0.6% | 68.8 | 4,393,714 | +39,213 | 5 | — |
| ☆VCEL funds › | VERICEL CORP | TRIM | — | 2.2% | -1.1% | 64.9 | 1,459,152 | -1,089,927 | 5 | — |
| ☆PRAX funds › | PRAXIS PRECISION MEDICINES I | TRIM | — | 2.0% | -2.3% | 59.4 | 177,517 | -153,000 | 5 | — |
| ☆GERN funds › | GERON CORP | ADD | — | 1.9% | -0.6% | 54.8 | 42,808,659 | +1,300,000 | 5 | — |
| ☆ALKS funds › | ALKERMES PLC | TRIM | — | 1.9% | -1.0% | 53.9 | 1,029,252 | -941,612 | 3 | — |
| ☆ERAS funds › | ERASCA INC | NEW | — | 1.7% | +1.7% | 49.5 | 2,700,000 | +2,700,000 | 1 | — |
| ☆NPCE funds › | NEUROPACE INC | TRIM | — | 1.6% | +0.0% | 46.3 | 2,911,122 | -21,085 | 5 | — |
| ☆PGNY funds › | PROGYNY INC | TRIM | — | 1.6% | +0.2% | 46.2 | 1,602,000 | -465,000 | 2 | — |
| ☆INDV funds › | INDIVIOR PHARMACEUTICALS INC | TRIM | — | 1.5% | -0.1% | 43.7 | 1,064,000 | -210,000 | 2 | — |
| ☆PBLS funds › | PARABILIS MEDICINES INC | NEW | — | 1.4% | +1.4% | 40.1 | 1,465,070 | +1,465,070 | 1 | — |
| ☆FOCL funds › | EDAP TMS S A | HOLD | — | 1.3% | +0.2% | 37.9 | 7,309,254 | +0 | 5 | — |
| ☆GMED funds › | GLOBUS MED INC | TRIM | — | 1.3% | -1.3% | 37.0 | 468,922 | -260,545 | 4 | — |
| ☆RCUS funds › | ARCUS BIOSCIENCES INC | ADD | — | 1.2% | +0.8% | 36.0 | 1,168,738 | +716,755 | 3 | — |
| ☆SNDX funds › | SYNDAX PHARMACEUTICALS INC | TRIM | — | 1.2% | -0.4% | 35.6 | 1,628,039 | -98,869 | 5 | — |
| ☆NRIX funds › | NURIX THERAPEUTICS INC | ADD | — | 1.2% | +0.6% | 35.5 | 1,465,163 | +527,000 | 5 | — |
| ☆LEGN funds › | LEGEND BIOTECH CORP | NEW | — | 1.2% | +1.2% | 34.8 | 1,205,000 | +1,205,000 | 1 | — |
| ☆JBIO funds › | JADE BIOSCIENCES INC | ADD | — | 1.2% | +0.7% | 34.5 | 1,550,690 | +753,946 | 5 | — |
| ☆UNH funds › | UNITEDHEALTH GROUP INC | NEW | — | 1.1% | +1.1% | 33.3 | 80,000 | +80,000 | 1 | — |
| ☆AVTX funds › | AVALO THERAPEUTICS INC | ADD | — | 1.1% | +0.8% | 30.6 | 1,654,978 | +1,213,000 | 3 | — |
| ☆URGN funds › | UROGEN PHARMA LTD | ADD | — | 1.1% | +0.5% | 30.5 | 829,810 | +102,810 | 5 | — |
| ☆MBX funds › | MBX BIOSCIENCES INC | ADD | — | 1.0% | +0.8% | 28.4 | 515,279 | +336,382 | 4 | — |
| ☆PALI funds › | PALISADE BIO INC | NEW | — | 0.9% | +0.9% | 27.3 | 13,063,687 | +13,063,687 | 1 | — |
| ☆PHVS funds › | PHARVARIS N V | ADD | — | 0.9% | +0.1% | 25.3 | 730,907 | +28,855 | 5 | — |
| ☆ORGO funds › | ORGANOGENESIS HLDGS INC | ADD | — | 0.8% | -0.1% | 24.6 | 10,140,951 | +55,000 | 5 | — |
| ☆SUPN funds › | SUPERNUS PHARMACEUTICALS | NEW | — | 0.8% | +0.8% | 24.2 | 520,000 | +520,000 | 1 | — |
| ☆PRCT funds › | PROCEPT BIOROBOTICS CORP | ADD | — | 0.8% | +0.6% | 22.6 | 1,003,000 | +843,000 | 2 | — |
| ☆TNGX funds › | TANGO THERAPEUTICS INC | ADD | — | 0.8% | +0.4% | 22.2 | 709,000 | +259,000 | 5 | — |
| ☆IKT funds › | INHIBIKASE THERAPEUTICS INC | HOLD | — | 0.8% | +0.0% | 22.1 | 10,875,000 | +0 | 5 | — |
| ☆TRVI funds › | TREVI THERAPEUTICS INC | TRIM | — | 0.8% | -0.0% | 22.0 | 1,179,618 | -440,382 | 5 | — |
| ☆BMRN funds › | BIOMARIN PHARMACEUTICAL INC | TRIM | — | 0.7% | -0.7% | 21.5 | 375,572 | -275,000 | 5 | — |
| ☆LIVN funds › | LIVANOVA PLC | TRIM | — | 0.7% | -0.8% | 21.0 | 254,957 | -327,543 | 3 | — |
| ☆ARGX funds › | ARGENX SE | ADD | — | 0.6% | +0.5% | 18.5 | 19,955 | +16,455 | 5 | — |
| ☆NVCT funds › | NUVECTIS PHARMA INC | NEW | — | 0.6% | +0.6% | 18.4 | 1,000,000 | +1,000,000 | 1 | — |
| ☆CAPR funds › | CAPRICOR THERAPEUTICS INC | NEW | — | 0.6% | +0.6% | 18.3 | 761,737 | +761,737 | 1 | — |
| ☆EWTX funds › | EDGEWISE THERAPEUTICS INC | TRIM | — | 0.6% | -1.2% | 18.3 | 450,889 | -999,026 | 3 | — |
| ☆PRLD funds › | PRELUDE THERAPEUTICS INC | NEW | — | 0.6% | +0.6% | 18.0 | 3,378,378 | +3,378,378 | 1 | — |
| ☆XENE funds › | XENON PHARMACEUTICALS INC | TRIM | — | 0.6% | -0.1% | 16.1 | 267,000 | -25,000 | 2 | — |
| ☆CCCC funds › | C4 THERAPEUTICS INC | TRIM | — | 0.5% | +0.1% | 15.8 | 3,377,981 | -425,961 | 5 | — |
| ☆KNSA funds › | KINIKSA PHARMACEUTICALS INTL | TRIM | — | 0.5% | -0.5% | 15.8 | 246,353 | -275,000 | 5 | — |
| ☆KIDS funds › | ORTHOPEDIATRICS CORP | ADD | — | 0.5% | +0.1% | 14.0 | 732,144 | +116,697 | 5 | — |
| ☆AVLN funds › | AVALYN PHARMACEUTICALS INC | NEW | — | 0.5% | +0.5% | 13.8 | 419,000 | +419,000 | 1 | — |
| ☆BDSX funds › | BIODESIX INC | ADD | — | 0.5% | +0.2% | 13.2 | 585,958 | +169,359 | 2 | — |
| ☆SYRE funds › | SPYRE THERAPEUTICS INC | NEW | — | 0.4% | +0.4% | 13.1 | 147,000 | +147,000 | 1 | — |
| ☆TWST funds › | TWIST BIOSCIENCE CORP | TRIM | — | 0.4% | -2.0% | 10.8 | 104,629 | -1,122,000 | 5 | — |
| ☆VIR funds › | VIR BIOTECHNOLOGY INC | TRIM | — | 0.4% | -0.4% | 10.2 | 1,000,000 | -1,002,000 | 2 | — |
| ☆ALNY funds › | ALNYLAM PHARMACEUTICALS INC | TRIM | — | 0.3% | -1.4% | 9.9 | 33,050 | -98,600 | 5 | — |
| ☆IMVT funds › | IMMUNOVANT INC | ADD | — | 0.3% | +0.1% | 9.7 | 252,000 | +22,000 | 3 | — |
| ☆INSM funds › | INSMED INC | ADD | — | 0.3% | +0.3% | 9.6 | 90,250 | +80,000 | 5 | — |
| ☆SEPN funds › | SEPTERNA INC | HOLD | — | 0.3% | +0.0% | 9.2 | 275,000 | +0 | 5 | — |
| ☆SOPH funds › | SOPHIA GENETICS SA | TRIM | — | 0.3% | -0.1% | 9.0 | 1,565,000 | -285,000 | 2 | — |
| ☆NKTR funds › | NEKTAR THERAPEUTICS | NEW | — | 0.3% | +0.3% | 9.0 | 128,362 | +128,362 | 1 | — |
| ☆MIRM funds › | MIRUM PHARMACEUTICALS INC | TRIM | — | 0.3% | -1.2% | 8.8 | 75,000 | -325,306 | 5 | — |
| ☆AORT funds › | ARTIVION INC | NEW | — | 0.3% | +0.3% | 8.7 | 388,000 | +388,000 | 1 | — |
| ☆TNDM funds › | TANDEM DIABETES CARE INC | TRIM | — | 0.3% | -0.3% | 8.7 | 575,000 | -208,000 | 2 | — |
| ☆ELVN funds › | ENLIVEN THERAPEUTICS INC | TRIM | — | 0.3% | -0.1% | 8.4 | 165,677 | -65,192 | 3 | — |
| ☆SION funds › | SIONNA THERAPEUTICS INC | TRIM | — | 0.3% | -0.2% | 7.8 | 177,687 | -115,813 | 5 | — |
| ☆BLTE funds › | BELITE BIO INC | NEW | — | 0.3% | +0.3% | 7.8 | 50,524 | +50,524 | 1 | — |
| ☆CERS funds › | CERUS CORP | TRIM | — | 0.3% | -0.5% | 7.3 | 2,500,000 | -8,253,700 | 3 | — |
| ☆SLN funds › | SILENCE THERAPEUTICS PLC | NEW | — | 0.2% | +0.2% | 6.9 | 630,000 | +630,000 | 1 | — |
| ☆IMUX funds › | IMMUNIC INC | NEW | — | 0.2% | +0.2% | 6.9 | 450,000 | +450,000 | 1 | — |
| ☆IVVD funds › | INVIVYD INC | HOLD | — | 0.2% | -0.2% | 6.7 | 7,708,727 | +0 | 3 | — |
| ☆MRK funds › | MERCK & CO INC | TRIM | — | 0.2% | -0.8% | 6.4 | 50,000 | -153,000 | 2 | — |
| ☆RLMD funds › | RELMADA THERAPEUTICS INC | HOLD | — | 0.2% | -0.0% | 5.8 | 842,106 | +0 | 2 | — |
| ☆GPCR funds › | STRUCTURE THERAPEUTICS INC | ADD | — | 0.2% | +0.0% | 5.7 | 107,000 | +27,000 | 3 | — |
| ☆EOLS funds › | EVOLUS INC | TRIM | — | 0.2% | -0.2% | 5.7 | 822,428 | -1,422,932 | 5 | — |
| ☆ANL funds › | ADLAI NORTYE LTD | NEW | — | 0.2% | +0.2% | 4.7 | 405,523 | +405,523 | 1 | — |
| ☆ZNTL funds › | ZENTALIS PHARMACEUTICALS INC | NEW | — | 0.2% | +0.2% | 4.6 | 950,000 | +950,000 | 1 | — |
| ☆KPTI funds › | KARYOPHARM THERAPEUTICS INC | HOLD | — | 0.1% | +0.0% | 4.3 | 440,000 | +0 | 3 | — |
| ☆CNTX funds › | CONTEXT THERAPEUTICS INC | ADD | — | 0.1% | -0.6% | 3.9 | 7,063,141 | +100,000 | 2 | — |
| ☆LUNG funds › | PULMONX CORP | HOLD | — | 0.1% | -0.0% | 3.6 | 2,788,323 | +0 | 3 | — |
| ☆SABS funds › | SAB BIOTHERAPEUTICS INC | TRIM | — | 0.1% | -0.0% | 3.5 | 900,000 | -150,000 | 2 | — |
| ☆TECX funds › | TECTONIC THERAPEUTIC INC | TRIM | — | 0.1% | -0.0% | 3.5 | 101,684 | -20,000 | 2 | — |
| ☆AXGN funds › | AXOGEN INC | TRIM | — | 0.1% | -0.8% | 2.6 | 57,036 | -622,134 | 5 | — |
| ☆MSLE funds › | SATELLOS BIOSCIENCE INC | TRIM | — | 0.1% | -0.0% | 2.4 | 314,359 | -100,000 | 2 | — |
| ☆AVBP funds › | ARRIVENT BIOPHARMA INC | NEW | — | 0.1% | +0.1% | 1.7 | 50,000 | +50,000 | 1 | — |
| ☆CORT funds › | CORCEPT THERAPEUTICS INC | TRIM | — | 0.1% | -0.4% | 1.7 | 19,653 | -265,878 | 2 | — |
| ☆SLDB funds › | SOLID BIOSCIENCES INC | NEW | — | 0.1% | +0.1% | 1.5 | 150,000 | +150,000 | 1 | — |
| ☆VCYT funds › | VERACYTE INC | TRIM | — | 0.1% | -0.4% | 1.5 | 25,000 | -294,912 | 5 | — |
| ☆CGEM funds › | CULLINAN THERAPEUTICS INC | TRIM | — | 0.0% | -0.2% | 0.9 | 50,000 | -360,200 | 2 | — |
| ☆NSPR funds › | INSPIREMD INC | HOLD | — | 0.0% | -0.0% | 0.7 | 1,045,708 | +0 | 5 | — |
| ☆WGS funds › | GENEDX HOLDINGS CORP | NEW | — | 0.0% | +0.0% | 0.7 | 10,000 | +10,000 | 1 | — |
| ☆IOVA funds › | IOVANCE BIOTHERAPEUTICS INC | TRIM | — | 0.0% | -0.1% | 0.6 | 150,000 | -850,000 | 2 | — |
| ☆LRMR funds › | LARIMAR THERAPEUTICS INC | TRIM | — | 0.0% | -0.2% | 0.6 | 188,102 | -878,858 | 2 | — |
| ☆CGON funds › | CG ONCOLOGY INC | TRIM | — | 0.0% | -0.0% | 0.4 | 5,000 | -15,000 | 5 | — |
| ☆QNRX funds › | QUOIN PHARMACEUTICALS LTD | HOLD | — | 0.0% | -0.0% | 0.4 | 72,730 | +0 | 3 | — |
| ☆EQ funds › | EQUILLIUM INC | NEW | — | 0.0% | +0.0% | 0.3 | 90,000 | +90,000 | 1 | — |
| ☆NTRA funds › | NATERA INC | TRIM | — | 0.0% | -1.0% | 0.3 | 1,000 | -118,000 | 3 | — |
| ☆NEO funds › | NEOGENOMICS INC | TRIM | — | 0.0% | -0.0% | 0.1 | 10,000 | -165,000 | 3 | — |
| ☆COGT funds › | COGENT BIOSCIENCES INC | EXIT | — | 0.0% | -0.0% | 0.0 | 0 | -10,000 | 0 | — |
| ☆LBRX funds › | LB PHARMACEUTICALS INC | EXIT | — | 0.0% | -0.0% | 0.0 | 0 | -10,000 | 0 | — |
| ☆PCVX funds › | VAXCYTE INC | EXIT | — | 0.0% | -0.9% | 0.0 | 0 | -385,472 | 0 | — |
| ☆TVTX funds › | TRAVERE THERAPEUTICS INC | EXIT | — | 0.0% | -0.7% | 0.0 | 0 | -546,000 | 0 | — |
| ☆CTMX funds › | CYTOMX THERAPEUTICS INC. | EXIT | — | 0.0% | -0.1% | 0.0 | 0 | -300,000 | 0 | — |
| ☆JSPR funds › | JASPER THERAPEUTICS INC | EXIT | — | 0.0% | -0.0% | 0.0 | 0 | -276,312 | 0 | — |
| ☆ANAB funds › | ANAPTYSBIO INC | EXIT | — | 0.0% | -0.0% | 0.0 | 0 | -6,000 | 0 | — |
| ☆DXCM funds › | DEXCOM INC | EXIT | — | 0.0% | -0.4% | 0.0 | 0 | -140,000 | 0 | — |
| ☆TYRA funds › | TYRA BIOSCIENCES INC | EXIT | — | 0.0% | -0.0% | 0.0 | 0 | -10,000 | 0 | — |
| ☆ORKA funds › | ORUKA THERAPEUTICS INC | EXIT | — | 0.0% | -0.0% | 0.0 | 0 | -5,000 | 0 | — |
| ☆ICLR funds › | ICON PLC | EXIT | — | 0.0% | -0.9% | 0.0 | 0 | -192,000 | 0 | — |
| ☆STAA funds › | STAAR SURGICAL CO | EXIT | — | 0.0% | -0.0% | 0.0 | 0 | -20,000 | 0 | — |
| ☆CUSIP:4525EP101 funds › | IMMUNIC INC | EXIT | — | 0.0% | -0.2% | 0.0 | 0 | -4,500,000 | 0 | — |
| ☆ARWR funds › | ARROWHEAD PHARMACEUTICALS IN | EXIT | — | 0.0% | -0.1% | 0.0 | 0 | -28,479 | 0 | — |
| ☆ZYME funds › | ZYMEWORKS INC | EXIT | — | 0.0% | -0.0% | 0.0 | 0 | -10,000 | 0 | — |
| ☆INBX funds › | INHIBRX BIOSCIENCES INC | EXIT | — | 0.0% | -0.4% | 0.0 | 0 | -131,000 | 0 | — |
| ☆RAPP funds › | RAPPORT THERAPEUTICS INC | EXIT | — | 0.0% | -0.0% | 0.0 | 0 | -10,000 | 0 | — |
| ☆ETON funds › | ETON PHARMACEUTICALS INC | EXIT | — | 0.0% | -0.2% | 0.0 | 0 | -166,381 | 0 | — |
Point-in-time history
| Period | AUM ($M) | Positions | Turnover | Top-10 wt | Herfindahl | Quality Q | Skill | Universe |
|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 2,902 | 97 | 0.26 | 49% | 0.037 | 0.423 | — | in |
| 2026Q1 | 2,469 | 93 | 0.31 | 50% | 0.038 | 0.328 | — | in |
| 2025Q4 | 2,357 | 94 | 0.39 | 47% | 0.033 | 0.143 | — | in |
| 2025Q3 | 1,871 | 87 | 0.30 | 48% | 0.035 | 0.240 | — | in |
| 2025Q2 | 1,448 | 94 | 0.29 | 47% | 0.033 | 0.265 | — | entered |
| 2025Q1 | 1,275 | 74 | 0.00 | 51% | 0.036 | 0.000 | — | out |
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short.
JSON: /api/signals ·
/api/funds ·
/api/status